July 05, 2025
1 min watch
LAS VEGAS — On this video from Medical Trials on the Summit, Ashkan M. Abbey, MD, FASRS, FAAO, of Texas Retina Associates, discusses a number of pathways to deal with moist age-related macular degeneration.
“I believe we have to begin our remedies for moist AMD in additional of a multimodal vogue, attacking it by means of a number of pathways with the intention to get each higher efficacy and likewise sturdiness, hopefully, for our sufferers sooner or later,” Abbey advised Healio.
Printed by:
Sources/Disclosures
Collapse
Supply:
Healio Interviews
Disclosures:
Abbey stories being a advisor and principal investigator for EyePoint Prescribed drugs and Regenxbio.
